[
  {
    "ts": null,
    "headline": "Align Technology (ALGN) Up 3.6% Since Last Earnings Report: Can It Continue?",
    "summary": "Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=25095f775daf167a6c9befe4614616105ad38dc72935bbf7d96ba6213e02d9fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748619068,
      "headline": "Align Technology (ALGN) Up 3.6% Since Last Earnings Report: Can It Continue?",
      "id": 134906712,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=25095f775daf167a6c9befe4614616105ad38dc72935bbf7d96ba6213e02d9fe"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma solutions designed to accelerate clinical trials and companion diagnostic development.",
    "url": "https://finnhub.io/api/news?id=8ee3c5eb1f62a45b23697e361bab834ed81a7eba2e15efad0b1c8e84b4ab69bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748602800,
      "headline": "Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research",
      "id": 134900337,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma solutions designed to accelerate clinical trials and companion diagnostic development.",
      "url": "https://finnhub.io/api/news?id=8ee3c5eb1f62a45b23697e361bab834ed81a7eba2e15efad0b1c8e84b4ab69bb"
    }
  },
  {
    "ts": null,
    "headline": "Weitz Partners III Opportunity Fund Q1 2025 Commentary",
    "summary": "The Partners III Opportunity Fundâs Institutional Class returned -0.45% for the first quarter of 2025, comparing favorably to the Russell 3000 Indexâs return of -4.72%.",
    "url": "https://finnhub.io/api/news?id=da8cfa95344ccaca83ec538b7dc3a9dd78f7140f85d4404bab110e7e9f3fc588",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748599020,
      "headline": "Weitz Partners III Opportunity Fund Q1 2025 Commentary",
      "id": 134899752,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2043764026/image_2043764026.jpg?io=getty-c-w1536",
      "related": "LH",
      "source": "SeekingAlpha",
      "summary": "The Partners III Opportunity Fundâs Institutional Class returned -0.45% for the first quarter of 2025, comparing favorably to the Russell 3000 Indexâs return of -4.72%.",
      "url": "https://finnhub.io/api/news?id=da8cfa95344ccaca83ec538b7dc3a9dd78f7140f85d4404bab110e7e9f3fc588"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research",
    "summary": "Labcorp Holdings Inc: * LABCORP EXPANDS ONCOLOGY PORTFOLIO TO IMPROVE PATIENT CAREANDADVANCE CANCER RESEARCHSource text:Further company coverage: ...",
    "url": "https://finnhub.io/api/news?id=8083dae806bf0072be2cd7cbc581e03b100bac3d97806a993fd0dcde17c91c5d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748598090,
      "headline": "Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research",
      "id": 134897624,
      "image": "",
      "related": "LH",
      "source": "Finnhub",
      "summary": "Labcorp Holdings Inc: * LABCORP EXPANDS ONCOLOGY PORTFOLIO TO IMPROVE PATIENT CAREANDADVANCE CANCER RESEARCHSource text:Further company coverage: ...",
      "url": "https://finnhub.io/api/news?id=8083dae806bf0072be2cd7cbc581e03b100bac3d97806a993fd0dcde17c91c5d"
    }
  },
  {
    "ts": null,
    "headline": "Weitz Large Cap Equity Fund Q1 2025 Commentary",
    "summary": "Weitz Large Cap Equity Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=20be1557f8321ddb46f87971d737ec67a2d13c4703af4bb7743a8cf49610d101",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748582820,
      "headline": "Weitz Large Cap Equity Fund Q1 2025 Commentary",
      "id": 134893038,
      "image": "",
      "related": "LH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=20be1557f8321ddb46f87971d737ec67a2d13c4703af4bb7743a8cf49610d101"
    }
  },
  {
    "ts": null,
    "headline": "Supreme Court Weighs Certification Of A Class Including Uninjured Plaintiffs",
    "summary": "In Laboratory Corporation of America Holdings v. Davis , the Supreme Court has the opportunity to decide whether a federal court may certify a class action under Federal Rule of Civil Procedure 23...",
    "url": "https://finnhub.io/api/news?id=c544f153ce3db0472e66de4c6422ed79616a829888681933dc0a9501ba9a7e86",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748578390,
      "headline": "Supreme Court Weighs Certification Of A Class Including Uninjured Plaintiffs",
      "id": 134892664,
      "image": "",
      "related": "LH",
      "source": "Finnhub",
      "summary": "In Laboratory Corporation of America Holdings v. Davis , the Supreme Court has the opportunity to decide whether a federal court may certify a class action under Federal Rule of Civil Procedure 23...",
      "url": "https://finnhub.io/api/news?id=c544f153ce3db0472e66de4c6422ed79616a829888681933dc0a9501ba9a7e86"
    }
  }
]